SIERRA ONCOLOGY, INC.
2150 – 885 West Georgia Street
Vancouver, British Columbia, Canada V6C 3E8
August 11, 2020
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
| Attention: | Office of Life Sciences | |
Re: | Sierra Oncology, Inc. | |
| Registration Statement on Form S-3 | ||
| Filed August 6, 2020 | ||
| File No. 333-241443 | ||
Requested Date: | August 13, 2020 | |
Requested Time: | 4:00 p.m. Eastern Time | |
Ladies and Gentlemen:
Sierra Oncology, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to make the above-captioned Registration Statement on Form S-3 effective at the “Requested Date” and “Requested Time” set forth above or as soon thereafter as practicable.
The Registrant hereby authorizes Stephen Graham or Amanda Rose, both of whom are attorneys with the Registrant’s outside legal counsel, Fenwick & West LLP, to orally modify or withdraw this request for acceleration.
| Sincerely, | ||
| Sierra Oncology, Inc. | ||
| By: | /s/ Sukhi Jagpal | |
| Sukhi Jagpal | ||
| Chief Financial Officer | ||
| cc: | Stephen G. Dilly, President and Chief Executive Officer |
Sierra Oncology, Inc.
Stephen Graham, Esq.
Amanda Rose, Esq.
Fenwick & West LLP
